News
Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...
The AI models occasionally altered decisions based on patients’ personal characteristics, affecting priority for care and ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...
A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...
Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for cancer, announced a new partnership with the Experimental Drug Development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results